LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.31623
89.57 84.90 1191 7494 0.1589 0.5047
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
89.57 84.90 481 7494 0.0642 0.3078
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
89.57 84.90 1029 7494 0.1373 0.4710
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
91.27 84.90 1156 7420 0.1558 0.4991
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
91.27 84.90 1191 7420 0.1605 0.5061
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
91.27 84.90 500 7420 0.0674 0.3164
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
91.27 84.90 1022 7420 0.1377 0.4708
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
92.98 84.90 1167 7257 0.1608 0.5044
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
92.98 84.90 1199 7257 0.1652 0.5107
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
92.98 84.90 483 7257 0.0666 0.3112
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
92.98 84.90 1059 7257 0.1459 0.4818
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
94.68 84.90 1171 7000 0.1673 0.5102
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
94.68 84.90 1199 7000 0.1713 0.5158
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
94.68 84.90 456 7000 0.0651 0.3022
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
94.68 84.90 1007 7000 0.1439 0.4748
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
1
2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
I09
MCF 10A-H2B-mCherry Trametinib
1
2.66 84.90 783 285 2.7403 2.5569
MN20160318_Q02
I09
MCF 10A-H2B-mCherry Trametinib
1
2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
I10
MCF 10A-H2B-mCherry Trametinib
1
2.66 84.90 764 285 2.6738 2.5073
MN20160318_Q02
I10
MCF 10A-H2B-mCherry Trametinib
1
4.36 84.90 1 322 0.0031 -0.9004
MN20160318_Q02
I09
MCF 10A-H2B-mCherry Trametinib
1
4.36 84.90 873 322 2.7064 2.3539
MN20160318_Q02
I09
MCF 10A-H2B-mCherry Trametinib
1
4.36 84.90 1 322 0.0031 -0.9004
MN20160318_Q02
I10
MCF 10A-H2B-mCherry Trametinib
1
4.36 84.90 841 322 2.6072 2.2895
MN20160318_Q02
I10
MCF 10A-H2B-mCherry Trametinib
1
6.06 84.90 1 365 0.0027 -0.8787
MN20160318_Q02
I09
MCF 10A-H2B-mCherry Trametinib
1
6.06 84.90 964 365 2.6378 2.1700
MN20160318_Q02
I09